Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalifa A Bojang

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|December 22, 2006
RTS,S/AS02A for malariaKalifa A Bojang
Expert Opinion on Investigational Drugs|November 18, 2008
Novel therapies for the prevention of malariaKalifa A Bojang
Malaria Journal|July 3, 2013
Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the GambiaAbraham R Oduro, David J Conway, David Schellenberg, et al.
Plos One|November 11, 2011
Health centre surveys as a potential tool for monitoring malaria epidemiology by area and over timeAbraham R Oduro, Kalifa A Bojang, David J Conway, et al.
Malaria Journal|January 11, 2011
A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The GambiaSanie Sesay, Paul Milligan, Ensa Touray, et al.
The Journal of Infectious Diseases|December 28, 2006
Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selectionSpencer D Polley, Kevin K A Tetteh, Jennie M Lloyd, et al.
Plos Medicine|February 10, 2011
Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trialKalifa A Bojang, Francis Akor, Lesong Conteh, et al.
Plos One|June 25, 2010
Prevention of the recurrence of anaemia in Gambian children following discharge from hospitalKalifa A Bojang, Paul J M Milligan, David J Conway, et al.
Malaria Journal|January 8, 2016
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malariaShivang S Shah, Kirk A Rockett, Muminatou Jallow, et al.
Parasite Immunology|September 26, 2003
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malariaWolfram G Metzger, Daniel M N Okenu, David R Cavanagh, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|December 22, 2006
RTS,S/AS02A for malariaKalifa A Bojang
Expert Opinion on Investigational Drugs|November 18, 2008
Novel therapies for the prevention of malariaKalifa A Bojang
Malaria Journal|July 3, 2013
Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the GambiaAbraham R Oduro, David J Conway, David Schellenberg, et al.
Plos One|November 11, 2011
Health centre surveys as a potential tool for monitoring malaria epidemiology by area and over timeAbraham R Oduro, Kalifa A Bojang, David J Conway, et al.
Malaria Journal|January 11, 2011
A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The GambiaSanie Sesay, Paul Milligan, Ensa Touray, et al.
The Journal of Infectious Diseases|December 28, 2006
Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selectionSpencer D Polley, Kevin K A Tetteh, Jennie M Lloyd, et al.
Plos Medicine|February 10, 2011
Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trialKalifa A Bojang, Francis Akor, Lesong Conteh, et al.
Plos One|June 25, 2010
Prevention of the recurrence of anaemia in Gambian children following discharge from hospitalKalifa A Bojang, Paul J M Milligan, David J Conway, et al.
Malaria Journal|January 8, 2016
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malariaShivang S Shah, Kirk A Rockett, Muminatou Jallow, et al.
Parasite Immunology|September 26, 2003
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malariaWolfram G Metzger, Daniel M N Okenu, David R Cavanagh, et al.
Pageof 3